Send to

Choose Destination
Indian J Radiol Imaging. 2019 Oct-Dec;29(4):412-417. doi: 10.4103/ijri.IJRI_386_19. Epub 2019 Dec 31.

Samrakshan: An Indian Radiological and Imaging Association program to reduce perinatal mortality in India.

Author information

National Coordinator for Samrakshan IRIA, AMMA Center for Diagnosis and Preventive Medicine, Kochi, Kerala, India.
Indian Radiological and Imaging Association, Gujarat Imaging Center, Navrangpura, Ahmedabad, Gujarat, India.
Fetocare Magnum Imaging and Diagnostics, Trichy, Tamil Nadu, India.
Nethra Scans and Genetic Clinic, Tiruppur, Tamil Nadu, India.
Department of Radiology, Starcare Hospital, Kozhikode, Kerala, India.
Consultant Radiologist, Lisie Hospital, Ernakulam, Kerala, India.
Consultant Radiologist and Director, Jyothi Hospital, Vijay Nagar, Indore, Madhya Pradesh, India.
Consultant Radiologist and Director, Sampurna Sodani Diagnostic Clinic, LG-1, Morya Center, Indore, Madhya Pradesh, India.
Raj Sonography and X-Ray Clinic, Baiju Choraha, Nayapura, Guna, Madhya Pradesh, India.
Chief Research Mentor, AMMA Education Research Foundation, Kochi, Kerala, India.



India has a high perinatal mortality rate. The Indian Radiological and Imaging Association (IRIA) is supplementing efforts to address perinatal mortality in India through the Samrakshan program.


To describe various elements of the Samrakshan program that aims to reduce perinatal mortality in India.


Samrakshan focuses on two priority areas, preeclampsia (PE) and fetal growth restriction (FGR). Samrakshan aims at technical skill upgradation, specifically focused on improved interpretative ability, prognostic and therapeutic efficacy using Doppler studies, a free online learning platform and offline continuous medical educations (CMEs), building an evidence base from the program to develop policy and guidelines, and improving synergy with the RAKSHA program of IRIA and other fetal care stakeholders.


Two courses on Doppler studies focused on first trimester and third trimester, supplemented by case discussions and journal articles, have started on the online platform with 230 registrants. The first statewide CME was held at Indore. Samrakshan screening identified 10 (17.24%, 95% CI: 8.59, 29.43) women at high risk for preterm PE and 29 (50.00%, 95% CI 36.58, 63.42) women at high risk for FGR in the first trimester. Ten fetuses (7.63%, 95% CI: 3.72, 13.59) including 9 with stage 1 FGR were identified in the third-trimester screening.


Samrakshan is a flagship program of IRIA that aims to reduce perinatal mortality in India through a synergistic, holistic approach that complements and supplements existing efforts in India.


Doppler ultrasound; India; fetal growth restriction; perinatal mortality; preeclampsia; screening

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center